More FDA

View Older Stories View More Recent Stories

Nov 4, 2009 02:14PM BioCryst (BCRX) Jumps Higher After Canceling Conference Appearance

Nov 4, 2009 11:11AM Merriman Curhan Positive On Celldex Therapeutics (CLDX) After Results and Ahead of Events

Nov 4, 2009 09:07AM BioCryst (BCRX) Partner In Japan Files NDA for Peramivir

Nov 4, 2009 08:59AM RXi Pharmaceuticals (RXII) Data to Be Presented at Conference Today

Nov 4, 2009 08:34AM GenVec (GNVC) Up After FDA Grants Orphan Drug Designation for TNFerade

Nov 3, 2009 11:53AM InterMune (ITMN) Higher Following INFORM-1 Trial Data

Nov 2, 2009 11:05AM Human Genome (HGSI) Second Successful Trial Sets Stage For Benlysta Approval

Nov 2, 2009 10:40AM Cardium (CXM) Plans File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL

Nov 2, 2009 09:00AM Hemispherx (HEB) To Widen Program for Chronic Fatigue Syndrome, Provides Update on Ampligen

Nov 2, 2009 08:43AM Dendreon (DNDN) Completes Submission of Amended Biologics License Application for PROVENGE®

Nov 2, 2009 08:42AM Dendreon (DNDN) Completes Submission of Biologics License Application for PROVENGE

Nov 2, 2009 08:19AM GTx (GXTI) Says FDA Identified Two Deficiencies in the Complete Response Letter for Toremifene NDA

Nov 2, 2009 07:25AM Amylin (AMLN) and Takeda Enter Development Agreement for Obesity Treatments

Nov 2, 2009 07:23AM Amylin (AMLN) Announces BYETTA Approved As Stand-Alone Medication

Nov 2, 2009 06:51AM Human Genome (HGSI) and GlaxoSmithKline Announced That BENLYSTA Met the Primary Endpoint in Second Phase 3 Trial

Oct 30, 2009 12:35PM Geron (GERN) Announces Plan to Advance Clinical Development of Stem Cell Product; Will Enable Reinitiation of Phase I Trial

Oct 30, 2009 06:46AM Stereotaxis (STXS) Receives European Approval for Additional Magnetic Irrigated Catheter

Oct 29, 2009 10:12AM MannKind (MNKD) Reports Positive Data From Two Phase 1 Studies

Oct 29, 2009 10:11AM Celldex Therapeutics (CLDX) Announces Positive Results From Phase Studies of CDX-1307

Oct 29, 2009 09:52AM Transcept Pharmaceuticals (TSPT) Smashed After FDA Asks For More Info on Intermezzo

Oct 27, 2009 02:34PM FDA Panel Weighing If Human Genome's (HGSI) Drug Needs More Study

Oct 27, 2009 09:30AM PURE Bioscience (PURE) Hard Surface Disinfectant Effective Against H1NI

Oct 27, 2009 08:03AM Sinovac Biotech (SVA) Receives Third Order For H1NI Vaccine In China

Oct 26, 2009 04:37PM Icagen (ICGN) Senicapoc Fails In Phase IIa Study

Oct 26, 2009 01:58PM GTX Inc (GTXI) November 10 straddle at $4.95 into results

Oct 26, 2009 09:57AM Gilead Sciences (GILD) Announced that Aztreonam for Inhalation to be Reviewed by U.S. FDA

Oct 26, 2009 09:36AM Impax Laboratories (IPXL) Initiates Phase III Trial of IPX066 in Parkinson's

Oct 26, 2009 09:06AM SuperGen (SUPG) Jumps 20% On Collaboration With GlaxoSmithKline (GSK)

Oct 26, 2009 09:00AM Japanese NIH Expanded the Data on Ampligen For Pandemic Flu

Oct 26, 2009 08:24AM Matrixx (MTXX) Shares Tumble as FDA Won't Reverse Position on Zicam

Oct 26, 2009 07:05AM Shire (SHPGY) Gets 5-Year NCE from US FDA for ADHD Treatment VYVANSE

Oct 26, 2009 07:04AM BioCryst (BCRX) Higher After Peramivir Granted Emergency Use Authorization

Oct 23, 2009 10:36AM Elan (ELN) and Biogen (BIIB) Weak On Jump In Tysabri PML Cases

Oct 23, 2009 08:30AM Headlines from Bloomberg, FDA says Human Genome Sciences (HGSI) anthrax treatment may not work

Oct 22, 2009 08:31AM Amgen (AMGN) Lower Despite Q3 Beat As Company Looks To Address Prolia Issues with FDA (Update)

Oct 21, 2009 08:40AM CombinatoRx (CRXX) Reports Positive Efficacy Results From Synavive Trial

Oct 21, 2009 08:35AM King Pharmaceuticals (KG) Receive Complete Reponse Letter from FDA on CorVue

Oct 20, 2009 03:24PM Teva Pharmaceutical (TEVA) Reported Positive Results from MediWond Debrase Trial

Oct 20, 2009 02:09PM Sangamo (SGMO) to Present Top-Line, Statistically Significant Phase 2 Data from ZFP Therapeutic(TM) Program

Oct 20, 2009 08:36AM BioSante (BPAX) Gets Green Light to Continue LibiGel Study

Oct 20, 2009 08:34AM Medco Health (MHS) Plans Head-to-Head Study of Plavix and Effient

Oct 19, 2009 04:36PM Angiotech Pharmaceuticals (ANPI) Receives FDA Letter Regarding 510k Submission of Bio-Seal

Oct 19, 2009 09:34AM Perrigo (PRGO) Says Duac Patent Litigation Dismissed

Oct 19, 2009 09:26AM Rexahn (RNN) Announces Positive Top-Line Results From Phase IIa Study of SerdaxinTM

Oct 19, 2009 08:49AM Immunomedics (IMMU) Awarded 2 Small Business Grants from NIH

Oct 19, 2009 08:47AM Endo Pharmaceuticals (ENDP) Receives Complete Response From FDA On FORTESTA

Oct 19, 2009 08:33AM Johnson & Johnson (JNJ) Subsidiary Centocor Bio Announces Positive Phase III Simponi Results

Oct 19, 2009 08:18AM Amgen (AMGN) Receives Complete Response Letter from FDA For Prolia in Osteoporosis

Oct 19, 2009 07:31AM Talecris Bio (TLCR) Receives FDA Approval for PROLASTIN-C

Oct 19, 2009 07:06AM Human Genome (HGSI) Receives $75M Payment from Novartis AG (NVS) for Zalbin Hep C Treatment

View More Recent Stories View Older Stories